Long-term effects of weight-reducing diets in people with hypertension

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 3, 2016, Pages

  Semlitsch, Thomas ^a   Jeitler, Klaus ^a   Berghold, Andrea ^a   Horvath, Karl ^a   Posch, Nicole ^a   Poggenburg, Stephanie ^a   Siebenhofer, Andrea ^a,b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; EMBASE; HAZARD RATIO; HUMAN; HYPERTENSION; LONG TERM CARE; MEDLINE; META ANALYSIS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WEIGHT REDUCTION; ADVERSE EFFECTS; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; LOW CALORY DIET; MIDDLE AGED;

AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIET, REDUCING; HUMANS; HYPERTENSION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 84961872395     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008274.pub3     Document Type: Review

References (188)

1. Cohen MD, D'Amico FJ, Merenstein JH. Weight reduction in obese hypertensive patients. Family Medicine 1991;23(1):25-8. [PUBMED: 2001777]
2. Croft PR, Brigg D, Smith S, Harrison CB, Branthwaite A, Collins MF. How useful is weight reduction in the management of hypertension?. The Journal of the Royal College of General Practitioners 1986;36(291):445-8. [PUBMED: 3440987]
3. Blaufox MD, Langford HG, Oberman A, Hawkins CM, Wassertheil-Smoller SW, Cutter GR. Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 1984;2(3):S179-81. [PUBMED: 6599665]
4. Langford HG, Blaufox MD, Oberman A, Hawkins CM, Curb JD, Cutter GR, et al. Dietary therapy slows the return of hypertension after stopping prolonged medication. JAMA 1985;253(5):657-64. [PUBMED: 3881608]
5. Langford HG, Blaufox MD, Oberman A, Hawkins CM, Curb JD, Cutter GR, et al. Return of hypertension after withdrawal of prolonged antihypertensive therapy, effect of weight loss, sodium reduction, and baseline factors. Transactions of the Association of American Physicians 1984;97:190-6. [PUBMED: 6535339]
6. Jalkanen L. The effect of a weight reduction program on cardiovascular risk factors among overweight hypertensives in primary health care. Scandinavian Journal of Social Medicine 1991;19(1):66-71. [PUBMED: 1925430]
7. Anderssen S, Holme I, Urdal P, Hjermann I. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES). Blood Pressure 1995;4(6):343-9. [PUBMED: 8746601]
8. Anderssen SA, Hjermann I, Urdal P, Torjesen PA, Holme I. Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial. Journal of Internal Medicine 1996;240(4):203-9. [PUBMED: 8918511]
9. Jacobs DR Jr, Sluik D, Rokling-Andersen MH, Anderssen SA, Drevon CA. Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study. The American Journal of Clinical Nutrition 2009;89:509-17. [PUBMED: 19116328]
10. Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P. Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care 1997;20(1):26-31. [PUBMED: 9028689]
11. Urdal P, Haaland A, Hjermann I, Gjesdal K, Christian C, Sorensen M, et al. The Oslo Diet and Exercise Study (ODES): Design and objectives. Controlled Clinical Trials 1993;14(3):229-43.
12. Anderssen S, Holme I, Urdal P, Hjermann I. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES). Blood Pressure 1995;4(6):343-9. [PUBMED: 8746601]
13. Anderssen SA, Hjermann I, Urdal P, Torjesen PA, Holme I. Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial. Journal of Internal Medicine 1996;240(4):203-9. [PUBMED: 8918511]
14. Jacobs DR Jr, Sluik D, Rokling-Andersen MH, Anderssen SA, Drevon CA. Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study. The American Journal of Clinical Nutrition 2009;89:509-17. [PUBMED: 19116328]
15. Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P. Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care 1997;20(1):26-31. [PUBMED: 9028689]
16. Urdal P, Haaland A, Hjermann I, Gjesdal K, Christian C, Sorensen M, et al. The Oslo Diet and Exercise Study (ODES): Design and objectives. Controlled Clinical Trials 1993;14(3):229-43.
17. Anderssen S, Holme I, Urdal P, Hjermann I. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES). Blood Pressure 1995;4(6):343-9. [PUBMED: 8746601]
18. Anderssen SA, Hjermann I, Urdal P, Torjesen PA, Holme I. Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial. Journal of Internal Medicine 1996;240(4):203-9. [PUBMED: 8918511]
19. Jacobs DR Jr, Sluik D, Rokling-Andersen MH, Anderssen SA, Drevon CA. Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study. The American Journal of Clinical Nutrition 2009;89:509-17. [PUBMED: 19116328]
20. Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P. Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care 1997;20(1):26-31. [PUBMED: 9028689]
21. Urdal P, Haaland A, Hjermann I, Gjesdal K, Christian C, Sorensen M, et al. The Oslo Diet and Exercise Study (ODES): Design and objectives. Controlled Clinical Trials 1993;14(3):229-43.
22. Ruvolo G, Greco E, Speziale G, Di Natale M, Marino B. The effect on left ventricular mass of treatment with amlodipine and diet therapy in obese patients with arterial hypertension [Effetti sulla massa ventricolare sinistra del trattamento con amlodipina e dietoterapia in pazienti obesi affetti da ipertensione arteriosa.]. Minerva Cardioangiologica 1994;42(6):289-92. [PUBMED: 7936332]
23. Blaufox MD, Lee HB, Davis B, Oberman A, Wassertheil-Smoller S, Langford H. Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy. JAMA 1992;267(9):1221-5. [PUBMED: 1538559]
24. Davis BR, Blaufox MD, Hawkins CM, Langford HG, Oberman A, Swencionis C, et al. Trial of antihypertensive interventions and management. Design, methods, and selected baseline results. Controlled Clinical Trials 1989;10(1):11-30. [PUBMED: 2649308]
25. Davis BR, Blaufox MD, Oberman A, Wassertheil-Smoller S, Zimbaldi N, Cutler JA, et al. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Archives of Internal Medicine 1993;153(15):1773-82. [PUBMED: 8333814]
26. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Hawkins CM, Cutler JA, et al. Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group. Hypertension 1992;19(4):393-9. [PUBMED: 1555871]
27. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Zimbaldi N, Kirchner K, et al. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management. American Journal of Hypertension 1994;7(10 Pt 1):926-32. [PUBMED: 7826557]
28. Langford HG, Davis BR, Blaufox D, Oberman A, Wassertheil-Smoller S, Hawkins M, et al. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group. Hypertension 1991;17(2):210-7. [PUBMED: 1671380]
29. Oberman A, Wassertheil-Smoller S, Langford HG, Blaufox MD, Davis BR, Blaszkowski T, et al. Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Annals of Internal Medicine 1990;112(2):89-95. [PUBMED: 1967210]
30. Wassertheil-Smoller S, Blaufox MD, Davis BR, Kirchner K, Langford HG, Oberman A. The trial of antihypertensive interventions and management (TAIM). Nieren- und Hochdruckkrankheiten 1994;23 (Suppl 1):S22-7.
31. Wassertheil-Smoller S, Blaufox MD, Oberman AS, Langford HG, Davis BR, Wylie-Rosett J. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Archives of Internal Medicine 1992;152(1):131-6. [PUBMED: 1728908]
32. Wassertheil-Smoller S, Davis BR, Oberman A. The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk. Cardiovascular Risk Factors 1991;1(7):427-35.
33. Wassertheil-Smoller S, Oberman A, Blaufox MD, Davis B, Langford H. The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life. American Journal of Hypertension 1992;5(1):37-44. [PUBMED: 1736933]
34. Wylie-Rosett J, Wassertheil-Smoller S, Blaufox MD, Davis BR, Langford HG, Oberman A, et al. Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention. Journal of the American Dietetic Association 1993;93(4):408-15. [PUBMED: 8454808]
35. Blaufox MD, Lee HB, Davis B, Oberman A, Wassertheil-Smoller S, Langford H. Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy. JAMA 1992;267(9):1221-5. [PUBMED: 1538559]
36. Davis BR, Blaufox MD, Hawkins CM, Langford HG, Oberman A, Swencionis C, et al. Trial of antihypertensive interventions and management. Design, methods, and selected baseline results. Controlled Clinical Trials 1989;10(1):11-30. [PUBMED: 2649308]
37. Davis BR, Blaufox MD, Oberman A, Wassertheil-Smoller S, Zimbaldi N, Cutler JA, et al. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Archives of Internal Medicine 1993;153(15):1773-82. [PUBMED: 8333814]
38. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Hawkins CM, Cutler JA, et al. Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group. Hypertension 1992;19(4):393-9. [PUBMED: 1555871]
39. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Zimbaldi N, Kirchner K, et al. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management. American Journal of Hypertension 1994;7(10 Pt 1):926-32. [PUBMED: 7826557]
40. Langford HG, Davis BR, Blaufox D, Oberman A, Wassertheil-Smoller S, Hawkins M, et al. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group. Hypertension 1991;17(2):210-7. [PUBMED: 1671380]
41. Oberman A, Wassertheil-Smoller S, Langford HG, Blaufox MD, Davis BR, Blaszkowski T, et al. Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Annals of Internal Medicine 1990;112(2):89-95. [PUBMED: 1967210]
42. Wassertheil-Smoller S, Blaufox MD, Davis BR, Kirchner K, Langford HG, Oberman A. The trial of antihypertensive interventions and management (TAIM). Nieren- und Hochdruckkrankheiten 1994;23 (Suppl 1):S22-7.
43. Wassertheil-Smoller S, Blaufox MD, Oberman AS, Langford HG, Davis BR, Wylie-Rosett J. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Archives of Internal Medicine 1992;152(1):131-6. [PUBMED: 1728908]
44. Wassertheil-Smoller S, Davis BR, Oberman A. The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk. Cardiovascular Risk Factors 1991;1(7):427-35.
45. Wassertheil-Smoller S, Oberman A, Blaufox MD, Davis B, Langford H. The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life. American Journal of Hypertension 1992;5(1):37-44. [PUBMED: 1736933]
46. Wylie-Rosett J, Wassertheil-Smoller S, Blaufox MD, Davis BR, Langford HG, Oberman A, et al. Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention. Journal of the American Dietetic Association 1993;93(4):408-15. [PUBMED: 8454808]
47. Blaufox MD, Lee HB, Davis B, Oberman A, Wassertheil-Smoller S, Langford H. Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy. JAMA 1992;267(9):1221-5. [PUBMED: 1538559]
48. Davis BR, Blaufox MD, Hawkins CM, Langford HG, Oberman A, Swencionis C, et al. Trial of antihypertensive interventions and management. Design, methods, and selected baseline results. Controlled Clinical Trials 1989;10(1):11-30. [PUBMED: 2649308]
49. Davis BR, Blaufox MD, Oberman A, Wassertheil-Smoller S, Zimbaldi N, Cutler JA, et al. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Archives of Internal Medicine 1993;153(15):1773-82. [PUBMED: 8333814]
50. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Hawkins CM, Cutler JA, et al. Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group. Hypertension 1992;19(4):393-9. [PUBMED: 1555871]
51. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Zimbaldi N, Kirchner K, et al. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management. American Journal of Hypertension 1994;7(10 Pt 1):926-32. [PUBMED: 7826557]
52. Langford HG, Davis BR, Blaufox D, Oberman A, Wassertheil-Smoller S, Hawkins M, et al. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group. Hypertension 1991;17(2):210-7. [PUBMED: 1671380]
53. Oberman A, Wassertheil-Smoller S, Langford HG, Blaufox MD, Davis BR, Blaszkowski T, et al. Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Annals of Internal Medicine 1990;112(2):89-95. [PUBMED: 1967210]
54. Wassertheil-Smoller S, Blaufox MD, Davis BR, Kirchner K, Langford HG, Oberman A. The trial of antihypertensive interventions and management (TAIM). Nieren- und Hochdruckkrankheiten 1994;23 (Suppl 1):S22-7.
55. Wassertheil-Smoller S, Blaufox MD, Oberman AS, Langford HG, Davis BR, Wylie-Rosett J. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Archives of Internal Medicine 1992;152(1):131-6. [PUBMED: 1728908]
56. Wassertheil-Smoller S, Davis BR, Oberman A. The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk. Cardiovascular Risk Factors 1991;1(7):427-35.
57. Wassertheil-Smoller S, Oberman A, Blaufox MD, Davis B, Langford H. The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life. American Journal of Hypertension 1992;5(1):37-44. [PUBMED: 1736933]
58. Wylie-Rosett J, Wassertheil-Smoller S, Blaufox MD, Davis BR, Langford HG, Oberman A, et al. Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention. Journal of the American Dietetic Association 1993;93(4):408-15. [PUBMED: 8454808]
59. Blaufox MD, Lee HB, Davis B, Oberman A, Wassertheil-Smoller S, Langford H. Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy. JAMA 1992;267(9):1221-5. [PUBMED: 1538559]
60. Davis BR, Blaufox MD, Hawkins CM, Langford HG, Oberman A, Swencionis C, et al. Trial of antihypertensive interventions and management. Design, methods, and selected baseline results. Controlled Clinical Trials 1989;10(1):11-30. [PUBMED: 2649308]
61. Davis BR, Blaufox MD, Oberman A, Wassertheil-Smoller S, Zimbaldi N, Cutler JA, et al. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Archives of Internal Medicine 1993;153(15):1773-82. [PUBMED: 8333814]
62. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Hawkins CM, Cutler JA, et al. Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group. Hypertension 1992;19(4):393-9. [PUBMED: 1555871]
63. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Zimbaldi N, Kirchner K, et al. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management. American Journal of Hypertension 1994;7(10 Pt 1):926-32. [PUBMED: 7826557]
64. Langford HG, Davis BR, Blaufox D, Oberman A, Wassertheil-Smoller S, Hawkins M, et al. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group. Hypertension 1991;17(2):210-7. [PUBMED: 1671380]
65. Oberman A, Wassertheil-Smoller S, Langford HG, Blaufox MD, Davis BR, Blaszkowski T, et al. Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Annals of Internal Medicine 1990;112(2):89-95. [PUBMED: 1967210]
66. Wassertheil-Smoller S, Blaufox MD, Davis BR, Kirchner K, Langford HG, Oberman A. The trial of antihypertensive interventions and management (TAIM). Nieren- und Hochdruckkrankheiten 1994;23 (Suppl 1):S22-7.
67. Wassertheil-Smoller S, Blaufox MD, Oberman AS, Langford HG, Davis BR, Wylie-Rosett J. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Archives of Internal Medicine 1992;152(1):131-6. [PUBMED: 1728908]
68. Wassertheil-Smoller S, Davis BR, Oberman A. The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk. Cardiovascular Risk Factors 1991;1(7):427-35.
69. Wassertheil-Smoller S, Oberman A, Blaufox MD, Davis B, Langford H. The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life. American Journal of Hypertension 1992;5(1):37-44. [PUBMED: 1736933]
70. Wylie-Rosett J, Wassertheil-Smoller S, Blaufox MD, Davis BR, Langford HG, Oberman A, et al. Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention. Journal of the American Dietetic Association 1993;93(4):408-15. [PUBMED: 8454808]
71. Blaufox MD, Lee HB, Davis B, Oberman A, Wassertheil-Smoller S, Langford H. Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy. JAMA 1992;267(9):1221-5. [PUBMED: 1538559]
72. Davis BR, Blaufox MD, Hawkins CM, Langford HG, Oberman A, Swencionis C, et al. Trial of antihypertensive interventions and management. Design, methods, and selected baseline results. Controlled Clinical Trials 1989;10(1):11-30. [PUBMED: 2649308]
73. Davis BR, Blaufox MD, Oberman A, Wassertheil-Smoller S, Zimbaldi N, Cutler JA, et al. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Archives of Internal Medicine 1993;153(15):1773-82. [PUBMED: 8333814]
74. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Hawkins CM, Cutler JA, et al. Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group. Hypertension 1992;19(4):393-9. [PUBMED: 1555871]
75. Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Zimbaldi N, Kirchner K, et al. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management. American Journal of Hypertension 1994;7(10 Pt 1):926-32. [PUBMED: 7826557]
76. Langford HG, Davis BR, Blaufox D, Oberman A, Wassertheil-Smoller S, Hawkins M, et al. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group. Hypertension 1991;17(2):210-7. [PUBMED: 1671380]
77. Oberman A, Wassertheil-Smoller S, Langford HG, Blaufox MD, Davis BR, Blaszkowski T, et al. Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Annals of Internal Medicine 1990;112(2):89-95. [PUBMED: 1967210]
78. Wassertheil-Smoller S, Blaufox MD, Davis BR, Kirchner K, Langford HG, Oberman A. The trial of antihypertensive interventions and management (TAIM). Nieren- und Hochdruckkrankheiten 1994;23 (Suppl 1):S22-7.
79. Wassertheil-Smoller S, Blaufox MD, Oberman AS, Langford HG, Davis BR, Wylie-Rosett J. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Archives of Internal Medicine 1992;152(1):131-6. [PUBMED: 1728908]
80. Wassertheil-Smoller S, Davis BR, Oberman A. The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk. Cardiovascular Risk Factors 1991;1(7):427-35.
81. Wassertheil-Smoller S, Oberman A, Blaufox MD, Davis B, Langford H. The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life. American Journal of Hypertension 1992;5(1):37-44. [PUBMED: 1736933]
82. Wylie-Rosett J, Wassertheil-Smoller S, Blaufox MD, Davis BR, Langford HG, Oberman A, et al. Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention. Journal of the American Dietetic Association 1993;93(4):408-15. [PUBMED: 8454808]
83. Appel LJ, Espeland M, Whelton PK, Dolecek T, Kumanyika S, Applegate WB, et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology 1995;5(2):119-29. [PUBMED: 7795830]
84. Bahnson JL, Whelton PK, Appel LJ, Espeland MA, Wofford JL, Rosen R, et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management & Clinical Outcomes 1997;1(2):61-8.
85. Espeland MA, Whelton PK, Kostis JB, Bahnson JL, Ettinger WH, Cutler JA, et al. Predictors and mediators of successful long-term withdrawal from antihypertensive medications. Archives of Family Medicine 1999;8(3):228-36. [PUBMED: 10333818]
86. Fessler B. Sodium reduction and weight loss instead of treatment with antihypertensive agents. [German]. Deutsche Apotheker Zeitung 1998;138(26):36-9.
87. Kostis JB, Wilson AC, Shindler DM, Cosgrove NM, Lacy CR. Persistence of normotension after discontinuation of lifestyle intervention in the trial of TONE. Trial of Nonpharmacologic Interventions in the Elderly. American Journal of Hypertension 2002;15(8):732-4. [PUBMED: 12160197]
88. Kumanyika SK, Espeland MA, Bahnson JL, Bottom JB, Charleston JB, Folmar S, et al. Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly. Obesity Research 2002;10(2):96-106. [PUBMED: 11836455]
89. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998;279(11):839-46. [PUBMED: 9515998]
90. Hypertension Prevention Collaborative Research Group. The impact of weight loss on blood pressure. Patient Care 1993;27(17):16.
91. Abou-Raya A, Abou-Raya S, Helmii M. Effect of exercise and dietary weight loss on symptoms and systemic inflammation in obese adults with psoriatic arthritis: Randomized controlled trial. Annals of the Rheumatic Diseases 2014;73(Suppl 2):89-90.
92. Andersen TR, Nielsen PE. Blood pressure lowering effect of weight reduction. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum 1985;176:7-14. [PUBMED: 3864228]
93. Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. The Lancet 2011;378(9786):129-39. [PUBMED: 21705068]
94. Angelico F, Del Ben M, Pacella A, Carnevale R, Loffredo L, Violi F. Low-fat, low-calorie, Mediterranean-style diet improves endothelial dysfunction in patients with the metabolic syndrome. Journal of Diabetes 2009;1(Suppl 1):A43.
95. Appel LJ, Sacks FM, Carey VJ, Conlin PR, Erlinger TP, Miller ER III. The effects of macronutrient intake on blood pressure: Subgroup analyses from the OmniHeart randomized feeding study. Journal of Hypertension 2006;24(Suppl 6):177.
96. Ard JD, Svetkey LP. Diet and blood pressure: applying the evidence to clinical practice. American Heart Journal 2005;149(5):804-12. [PUBMED: 15894960]
97. Balas-Nakash M, Munoz-Manrique C, Legorreta-Legorreta J, Rodriguez-Cano A, Mier-Cabrera J, Aguilera-Perez JR. Structured hypocaloric diet is more effective than behavioral therapy in reducing metabolic syndrome in Mexican postmenopausal women: a randomized controlled trial. Menopause 2014;21(7):711-20. [PUBMED: 24378762]
98. Bao DQ, Mori TA, Burke V, Puddey IB, Beilin LJ. Dietary fish and weight reduction improves multiple risk factors in overweight, treated hypertensives. [abstract]. Australian & New Zealand Journal of Medicine 1999;29:148.
99. Bartels RW, Bigalke C, Mollmann H, Schneeberger W, Wessels F. Influence of various hunger-cures on the behavior of body weight and blood pressure as well as on relevant blood parameters [Der Einfluss unterschiedlicher Fastenkuren auf das Gewichts- und Blutdruckverhalten sowie auf relevante metabolische Blutparameter]. Die Medizinische Welt 1974;25(17):725-35. [PUBMED: 4421950]
100. Bazian Ltd. Advice about diet and lifestyle does not reduce blood pressure in people with hypertension. Evidence-Based Healthcare and Public Health 2004;8(6):348-9.
101. Bouchonville M, Armamento-Villareal R, Shah K, Napoli N, Sinacore DR, Qualls C, et al. Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial. International Journal of Obesity 2014;38(3):423-31. [PUBMED: 23823329]
102. Bouchonville M, Krupa S, Armamento-Villareal R, Sinacore DR, Qualls C, Villareal DT. Weight Loss, Exercise, or Both and Cardiometabolic Risk Factors in Obese Older Adults: Results of a Randomized Controlled Trial. Endocrine Reviews 2012;33(Suppl 3):S18. [DOI: 10.1038/ijo.2013.122]
103. Cakir H, Pinar R. Randomized controlled trial on lifestyle modification in hypertensive patients. Western Journal of Nursing Research 2006;28(2):190-209.
104. Cambien F, Plouin PF, Safar M, Pequignot G, Guillanneuf MT, Dutemple C. Comparative study of a medical and a dietary intervention in overweight hypertensive patients [Essai comparant une intervention medicamenteuse et une intervention dietetique chez des patients ayant une hypertension associee a un surpoids]. Archives des Maladies du Coeur et des Vaisseaux 1986;79:1002.
105. Camhi SM, Stefanick ML, Katzmarzyk PT, Young DR. Metabolic syndrome and changes in body fat from a low-fat diet and/or exercise randomized controlled trial. Obesity 2010;18(3):548-54.
106. Chen L, Appel LJ, Loria C, Lin PH, Champagne CM, Elmer PJ, et al. Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial. The American Journal of Clinical Nutrition 2009;89(5):1299-306. [PUBMED: 19339405]
107. Childress S, Brubaker PH, Amico LA, Nesbit BA, Williams CM, Jack Rejeski W. Patterns of physical activity before and after an exercise intervention in overweight/obese older adults with CVD or the metabolic syndrome. Journal of Cardiopulmonary Rehabilitation and Prevention 2008;28(4):268.
108. Christensen P, Frederiksen R, Bliddal H, Riecke BF, Bartels EM, Henriksen M, et al. Comparison of three weight maintenance programs on cardiovascular risk, bone and vitamins in sedentary older adults. Obesity 2013;21(10):1982-90. [PUBMED: 23512743]
109. Coppell KJ, Kataoka M, Williams SM, Chisholm AW, Vorgers SM, Mann JI. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment - Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial. BMJ 2010;341:c3337. [PUBMED: 20647285]
110. Curzio JL, Kennedy SS, Elliott HL, Farish E, Barnes JF, Howie CA, et al. Hypercholesterolaemia in treated hypertensives: a controlled trial of intensive dietary advice. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 1989;7(6):S254-5. [PUBMED: 2698935]
111. Cutler JA, Stamler J. Chapter 1. Introduction and summary of the dietary and nutritional methods and findings in the Multiple Risk Factor Intervention Trial. American Journal of Clinical Nutrition 1997;65 (1 Suppl):184S-90S.
112. De Mello VDF, Kolehmainen M, Pulkkinen L, Schwab U, Mager U, Laaksonen DE, et al. Downregulation of genes involved in NFB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: The GENOBIN study. Diabetologia 2008;51(11):2060-7.
113. Diaz KM, Muntner P, Levitan EB, Brown MD, Babbitt DM, Shimbo D. The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: results from a multicenter randomized controlled trial. Journal of Hypertension 2014;32(4):840-8. [PUBMED: 24366034]
114. Ebell MH. Intensive lifestyle intervention fails to improve patient-oriented outcomes in persons with obesity and diabetes. American Family Physician 2013;88(12):864A.
115. Fagerberg B, Berglund A, Berglund G, Wikstrand J, Andersson OK. Food and health. Weight reduction and decreased sodium chloride intake depress blood pressure but not as much as drugs do [kost och halsa. Viktreduktion och minskat koksaltintag sanker blodtrycket mindre an lakemedel]. Lakartidningen 1989;86(51):4522-4. [PUBMED: 2689815]
116. Gilliam ML. Long-term effects of weight-reducing diets in hypertensive patients. Obstetrics and Gynecology 2012;119(1):180-1.
117. Gillum RF, Prineas RJ, Jeffery RW, Jacobs DR, Elmer PJ, Gomez O, et al. Nonpharmacologic therapy of hypertension: the independent effects of weight reduction and sodium restriction in overweight borderline hypertensive patients. American Heart Journal 1983;105(1):128-33. [PUBMED: 6849226]
118. Hall WD, Feng Z, George VA, Lewis CE, Oberman A, Huber M, et al. Low-fat diet: effect on anthropometrics, blood pressure, glucose, and insulin in older women. Ethnicity & Disease 2003;13(3):337-43. [PUBMED: 12894958]
119. Haynes RB, Harper AC, Costley SR, Johnston M, Logan AG, Flanagan PT, et al. Failure of weight reduction to reduce mildly elevated blood pressure: a randomized trial. Journal of Hypertension 1984;2(5):535-9. [PUBMED: 6397541]
120. Hayward CS, Lockwood J, Williams CD, Cole RE, Torres DM, Harrison SA. Lifestyle modification and NAFLD: A prospective, randomized trial. Hepatology 2010;52:622A.
121. He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000;35(2):544-9. [PUBMED: 10679495]
122. Heshka S, Anderson J, Atkinson R, Gadde KM, Nanchahal K. Commercial weight reduction programme reduces weight more than self-help materials. Evidence-Based Healthcare 2003;7(4):179-81.
123. Heyden S, Hames CG. Diet therapy of elevated blood pressure values in overweight persons. Hypertension-intervention study: 1 year's report from the Evans-County (Ga.) study [Diätbehandlung erhöhter Blutdruckwerte bei übergewichtigen Personen. Hypertonie-Interventionsstudie: 1-Jahres-Bericht aus der Evans-County (Ga.)-Studie]. Die Medizinische Welt 1974;25(49):2041-3. [PUBMED: 4444500]
124. Hsieh YC, Hung CT, Lien LM, Bai CH, Chen WH, Yeh CY, et al. A significant decrease in blood pressure through a family-based nutrition health education programme among community residents in Taiwan. Public Health Nutrition 2009;12(4):570-7. [PUBMED: 18561875]
125. Hyden S, Tyroler HA, Hames CG, Bartel A, Thompson JW, Krishan I, et al. Diet treatment of obese hypertensives. Clinical Science and Molecular Medicine. Supplement 1973;45 Suppl 1:209s-12. [PUBMED: 4593567]
126. Jones DW, Miller ME, Wofford MR, Anderson DC Jr, Cameron ME, Willoughby DL, et al. The effect of weight loss intervention on antihypertensive medication requirements in the Hypertension Optimal Treatment (HOT) study. American Journal of Hypertension 1999;12(12 Pt 1-2):1175-80. [PUBMED: 10619579]
127. Karoff C, Zidek W, Lange-Asschenfeldt H, Losse H, Vetter H. Blood pressure and intracellular electrolytes during weight reduction. Klinische Wochenschrift 1985;63 Suppl 3:129-31. [PUBMED: 3999629]
128. Karvetti RL, Hakala P. A seven-year follow-up of a weight reduction programme in Finnish primary health care. European Journal of Clinical Nutrition 1992;46(10):743-52. [PUBMED: 1425528]
129. Katzel LI, Bleecker ER, Colman EG, Rogus EM, Sorkin JD, Goldberg AP. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA 1995;274(24):1915-21. [PUBMED: 8568984]
130. Kawamura M, Akasaka T, Kasatsuki T, Nakajima J, Onodera S, Fujiwara T, et al. Blood pressure is reduced by short-time calorie restriction in overweight hypertensive women with a constant intake of sodium and potassium. Journal of hypertension. Supplement: Official Journal of the International Society of Hypertension 1993;11(5):S320-1. [PUBMED: 8158405]
131. Kittiskulnam P, Kanjanabuch T, Tangmanjitjaroen K, Chancharoenthana W, Praditpornsilpa K, Eiam-Ong S. The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin a nephropathy: a randomized controlled trial. Journal of Renal Nutrition 2014;24(3):200-7. [PUBMED: 24759301]
132. Kolehmainen M, Salopuro T, Schwab US, Kekalainen J, Kallio P, Laaksonen DE, et al. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: The GENOBIN study. International Journal of Obesity 2008;32(2):292-303.
133. Korhonen M, Kastarinen M, Uusitupa M, Stevens VJ, Worsley A. Advice from primary care physicians and nurses may improve diet in people with hypertension. Evidence-based Cardiovascular Medicine 2003;7:94-6.
134. Larson-Meyer DE, Redman L, Heilbronn LK, Martin CK, Ravussin E. Caloric restriction with or without exercise: the fitness versus fatness debate. Medicine and Science in Sports and Exercise 2010;42(1):152-9. [PUBMED: 20010118]
135. Lindgarde F. Orlistat with diet was effective and safe for weight loss and coronary risk reduction in obesity. Evidence-Based Medicine 2001;6(2):54.
136. Mason C, Foster-Schubert KE, Imayama I, Xiao L, Kong A, Campbell KL, et al. History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women. Metabolism: Clinical & Experimental 2013;62(1):127-36. [PUBMED: 22898251]
137. Masuo K, Rakugi H, Ogihara T, Lambert G. Effects of weight loss on liver function in obese hypertensive patients. Journal of Hypertension 2012;30:e53-4.
138. Masuo K, Rakugi H, Ogihara T, Lambert GW. Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise. Hypertension Research - Clinical & Experimental 2012;35(1):41-7. [PUBMED: 21814218]
139. Masuo K, Rakugi H, Ogihara T, Lambert GW. The effects of weight loss on liver function in obese hypertensive patients. Circulation 2012;125(Suppl 1):P131.
140. McCarron DA, Reusser ME. Cardiovascular risk reduction dietary intervention trial. Drug Benefit Trends 2000;12(5):42-8.
141. Metz JA, Stern JS, Kris-Etherton P, Reusser ME, Morris CD, Hatton DC, et al. A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction. Archives of Internal Medicine 2000;160(14):2150-8. [PUBMED: 10904458]
142. Noble RE. A controlled study of a weight reduction regimen. Current Therapeutic Research, Clinical and Experimental 1971;13(11):685-91. [PUBMED: 5000715]
143. Poppitt SD, Keogh GF, Prentice AM, Williams DE, Sonnemans HM, Valk EE, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. The American Journal of Clinical Nutrition 2002;75(1):11-20. [PUBMED: 11756055]
144. Pritchard JE, Nowson CA, Billington T, Wark JD. Benefits of a year-long workplace weight loss program on cardiovascular risk factors. Nutrition and Dietetics 2002;59:87-96.
145. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. The New England Journal of Medicine 1978;298(1):1-6. [PUBMED: 337144]
146. Rissanen A, Pietinen P, Siljamaki-Ojansuu U, Piirainen H, Reissel P. Treatment of hypertension in obese patients: efficacy and feasibility of weight and salt reduction programs. Acta Medica Scandinavica 1985;218(2):149-56. [PUBMED: 4061119]
147. Salas-Salvado J, Fernandez-Ballart J, Ros E, Martinez-Gonzalez MA, Fito M, Estruch R, et al. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: One-year results of the PREDIMED randomized trial. Archives of Internal Medicine 2008;168(22):2449-58.
148. Salinardi TC, Batra P, Roberts SB, Urban LE, Robinson LM, Pittas AG, et al. A lifestyle intervention reduces body weight and improves cardiometabolic risk factors in worksites. Circulation 2012;126(21 Suppl):A13112.
149. Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. The New England Journal of Medicine 2003;348(21):2074-81.
150. Schwab U, Seppanen-Laakso T, Yetukuri L, Agren J, Kolehmainen M, Laaksonen DE, et al. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism - The GENOBIN study. PLoS ONE 2008; Vol. 3, issue 7:e2630.
151. Stamler R, Stamler J, Grimm R, Gosch FC, Dyer A. Control of hypertension by regulating nutrition. The 4-year results [Issledovanie po kontroliu gipertonii s pomoshch'iu regulirovaniia pitaniia. Rezul'taty za 4 goda.]. Terapevticheskii Arkhiv 1985;57(11):71-6. [PUBMED: 4082027]
152. Tate DF, Turner-McGrievy G, Lyons E, Stevens J, Erickson K, Polzien K, et al. Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. American Journal of Clinical Nutrition 2012;95(3):555-63. [PUBMED: 22301929]
153. Tate DF, Turner-McGrievy G, Stevens J, Erickson K, Polzien K, Diamond M, et al. Replacing caloric beverages with water or diet beverages for weight loss in adults: Results of a 6-month randomized controlled trial. Obesity 2011;19(Suppl 1):S68.
154. Trepanowski J, Kroeger C, Klempel M, Calvo Y, Varady K. Alternate day fasting versus daily calorie restriction for weight loss and cardio-protection. The FASEB Journal 2014;28(1 Suppl):120.6.
155. Tunyan AM. Cardioprotective effects of antihypertensive therapy with orlistat treatment and hypocaloric diet in combination in obese hypertensive patients. Circulation 2007;115(8):e248.
156. Tuomilehto HPI, Seppa JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JOI, et al. Lifestyle intervention with weight reduction: First-line treatment in mild obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine 2009;179(4):320-7.
157. Vissers D, Verrijken A, Mertens I, Van Gils C, Van De Sompel A, Truijen S, et al. Effect of long-term whole body vibration training on visceral adipose tissue: A preliminary report. Obesity Facts 2010;3(2):93-100.
158. World Health Organization European Collaborative Group. An international controlled trail in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology 1974;3(3):219-24. [PUBMED: 4606212]
159. Yamada S, Yamada Y, Irie J. A non-calorie-restricted non-ketogenic low-carbohydrate diet is effective as an alternative therapy for patients with type 2 diabetes. Diabetes 2013;62:A192-3.
160. Anderssen S, Holme I, Urdal P, Hjermann I. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES). Blood Pressure 1995;4(6):343-9. [PUBMED: 8746601]
161. Aucott L, Poobalan A, Smith WC, Avenell A, Jung R, Broom J. Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension 2005;45(6):1035-41. [PUBMED: 15897373]
162. Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, et al. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Canadian Journal of Cardiology 2014;30(5):485-501. [PUBMED: 24786438]
163. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. Journal of Hypertension 2006;24(2):215-33. [PUBMED: 16508562]
164. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Pressure 2014;23(1):3-16. [PUBMED: 24359485]
165. Haynes B. RE: Cochrane Review [personal communication]. Email to: A Siebenhofer. 10 December 2010.
166. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org.
167. Horvath K, Jeitler K, Siering U, Stich AK, Skipka G, Gratzer TW, et al. Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis. Archives of Internal Medicine 2008;168(6):571-80. [PUBMED: 18362248]
168. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006;295(6):655-66. [PUBMED: 16467234]
169. Institute for Quality and Efficiency in Health Care (IQWiG). IQWiG Reports - Commission No. A05-21A: Benefit assessment of non-drug treatment strategies in patients with hypertension: weight reduction [Abschlussbericht A05/21-A: Nutzenbewertung nichtmedikamentöser Behandlungsstrategien bei Patienten mit Bluthochdruck: A-Gewichtsreduktion]. http://iqwig.de/download/A05-21A_Abschlussbericht_Gewichtsreduktion_bei_Bluthochdruck_neu.pdf. Köln, Germany, 2006.
170. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311(5):507-20. [PUBMED: 24352797]
171. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. The New England Journal of Medicine 2002;347(5):305-13. [PUBMED: 12151467]
172. Musini VM, Wright JM. Factors affecting blood pressure variability: Lessons learned from two systematic reviews of randomized controlled trials. PLoS ONE 22 May 2009;4(5):Article Number: e5673.
173. National Institute for Health and Clinical Excellence (NICE). Hypertension: the clinical management of primary hypertension in adults. 2011. Available from: http://www.nice.org.uk/nicemedia/live/13561/56007/56007.pdf (accessed 9 April 2015).
174. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009;151(4):264-9. [PUBMED: 19622511]
175. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version Version 5.3.. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
176. Siebenhofer A, Jeitler K, Horvath K, Berghold A, Siering U, Semlitsch T. Long-term effects of weight-reducing drugs in hypertensive patients. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD007654.pub3]
177. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. The New England Journal of Medicine 2004;351(26):2683-93. [PUBMED: 15616203]
178. Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertension research: Official Journal of the Japanese Society of Hypertension 2005;28(5):385-407. [PUBMED: 16156503]
179. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. The Lancet 2003;362(9395):1527-35. [PUBMED: 14615107]
180. Urdal P, Haaland A, Hjermann I, Gjesdal K, Christian C, Sorensen M, et al. The Oslo Diet and Exercise Study (ODES): Design and objectives. Controlled Clinical Trials 1993;14(3):229-43.
181. Wannamethee SG, Shaper AG. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke; a Journal of Cerebral Circulation 1996;27(6):1033-9. [PUBMED: 8650710]
182. World Health Organization. Khatib OMN, El-Guindy MS (editors). Clinical guidelines for the management of hypertension. WHO EMRO Technical Publications Series 29. Available from: http://www.emro.who.int/dsaf/dsa234.pdf (accessed 6 August 2008).
183. World Health Organization. World Health Day 2013 - A global brief on hypertension. 2013. Available from: http://www.who.int/iris/bitstream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.pdf (accessed 9 April 2015).
184. Wilhelm SM, Young J, Kale-Pradhan PB. Effect of bariatric surgery on hypertension: a meta-analysis. The Annals of Pharmacotherapy 2014;48(6):674-82. [PUBMED: 24662112]
185. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Archives of Internal Medicine 2002;162(16):1867-72. [PUBMED: 12196085]
186. Woodward M, Lam TH, Barzi F, Patel A, Gu D, Rodgers A, et al. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. International Journal of Epidemiology 2005;34(5):1036-45. [PUBMED: 15914503]
187. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 2004;364(9438):937-52. [PUBMED: 15364185]
188. Siebenhofer A, Jeitler K, Berghold A, Waltering A, Hemkens LG, Semlitsch T, et al. Long-term effects of weight-reducing diets in hypertensive patients. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI: 10.1002/14651858.CD008274.pub2]